Adline Chem Lab Ltd Management Discussions

Your Directors have pleasure in presenting the Management Discussion and Analysis Report for the year ended on 31^st March 2025.

a. Industry Structure and Developments:

The pharmaceutical industry is growing. The companies having chronic therapy products have registered growth. In case of our company we have got acute therapy products. So we are watching the developments. When the economics improves, we are hopeful of improvement.

b. Opportunities and Threats:

The opportunities in healthcare industry are many. Even today, only less than 50% of the Countrys population has access to proper medical facilities. With the development of hospitals, the growth opportunities of pharmaceutical industry are large. However due to Pandemic and Lockdown result into sales de-growth & are a threat for sales growth.

c. Segment wise Performance:

The Company is operating in one segment, The Companys product portfolio comprises of trading in pharmaceutical formulations and Nutraceuticals and Dietary.

d. Recent Trend and Future Outlook:

With the increase in availability of healthcare facilities, there will be an increase in demand for medicines and thus, the future looks promising.

e. Risks and Concerns:

The increase in market size may lead to increase in number of companies/competitors leading to increase in the competition.

f. Internal Control Systems and their Adequacy:

The Company has adequate systems of Internal Controls commensurate with its size and operations to ensure orderly and efficient conduct of business. These controls ensure safeguarding of assets, reduction and detection of fraud and error, adequacy and completeness of the accounting records and timely preparation of reliable financial information.

g. Financial Performance with respect to Operational Performance:

The financial performance of the Company for the year 2024-2025 is described in the Directors Report.

h. Material Developments in Human Resources and Industrial Relations Front:

Your Company has undertaken certain employees development initiatives, which have very positive impact on the morale and team spirit of the employees. The Company has continued to give special attention to Human Resources/Industrial Relations development. Industrial relations remained cordial throughout the year.

i. Currency Fluctuations:

Currency fluctuations can impact profitability. We employ hedging strategies to manage exchange rate risks.

j. Future Outlook:

Looking ahead, Adline Chem Lab Limited aims to maintain its growth trajectory through Innovation, Global Expansion, Operational Excellence: Enhancing manufacturing capabilities and adopting advanced technologies, Sustainability.

Date: 13.06.2025	By order of the Board,
Place: Ahmedabad	For, Adline Chem Lab Limited

 

SD/-	SD/-
Managing Director	Director
Pathak S. B.	Parikh H. A.
DIN: 02663344	DIN: 00027820